Electroporation Therapy in Soft Tissue Sarcoma: A Potentially Effective Novel Treatment

de Bree, Remco; Tijink, Bernard M.; van Groeningen, Cees J.; Leemans, C. René

doi:https://doi.org/10.1155/SRCM/2006/85234

Sarcoma

On this page

Abstract References Copyright Related Articles

Case Report | Open Access

Volume 2006 | Article ID 085234 | https://doi.org/10.1155/SRCM/2006/85234

Electroporation Therapy in Soft Tissue Sarcoma: A Potentially Effective Novel Treatment

Remco de Bree,¹Bernard M. Tijink,¹Cees J. van Groeningen,²and C. René Leemans¹

Received19 Nov 2005

Accepted23 May 2006

Published13 Jul 2006

Abstract

Purpose. Examination of the potential of electroporation therapy (EPT) in a patient with metastatic soft tissue sarcoma. Patient. A 24-year-old male who underwent extensive resection and postoperative radiotherapy for a malignant peripheral nerve sheath tumor in the right infratemporal fossa with intracranial extension and invasion of the maxillary sinus and mandible had a recurrence in the scar of his craniotomy for which he was initially treated with doxorubicin. After discontinuation of doxorubicin he developed a metastatic mass at the same site for which he was treated with electroporation therapy. Method. The subcutaneous metastasis was infiltrated with bleomycin and electroporated. Results. Gradually the tumor became increasingly necrotic and demarcated from surrounding tissue. After 10 weeks no tumor was seen anymore. The wound healed secondarily. Discussion. Intralesional bleomycin followed by EPT is potentially effective, well tolerated, and easy to perform in well accessible soft tissue sarcoma sites.

References

R A Eeles, C Fisher, R P A'Hern et al., “Head and neck sarcomas: prognostic factors and implications for treatment,” British Journal of Cancer, vol. 68, no. 1, pp. 201–207, 1993.
View at: Google Scholar
L M Tran, R Mark, R Meier, T C Calcaterra, and R G Parker, “Sarcomas of the head and neck: prognostic factors and treatment strategies,” Cancer, vol. 70, no. 1, pp. 169–177, 1992.
View at: Google Scholar
J LeVay, B O'Sullivan, C Catton et al., “Outcome and prognostic factors in soft tissue sarcoma in the adult,” International Journal of Radiation Oncology Biology Physics, vol. 27, no. 5, pp. 1091–1099, 1993.
View at: Google Scholar
E M Sturgis and B O Potter, “Sarcomas of the head and neck region,” Current Opinion in Oncology, vol. 15, no. 3, pp. 239–252, 2003.
View at: Publisher Site | Google Scholar
G K Zagars, M T Ballo, P WT Pisters et al., “Prognostic factors for patients with localized soft-tissue sarcoma treated with conservation surgery and radiation therapy: an analysis of 1225 patients,” Cancer, vol. 97, no. 10, pp. 2530–2543, 2003.
View at: Publisher Site | Google Scholar
J H Edmonson, “Chemotherapeutic approaches to soft tissue sarcomas,” Seminars in Surgical Oncology, vol. 10, no. 5, pp. 357–363, 1994.
View at: Google Scholar
E Neumann, S Kakorin, and K Tœnsing, “Fundamentals of electroporative delivery of drugs and genes,” Bioelectrochemistry and Bioenergetics, vol. 48, no. 1, pp. 3–16, 1999.
View at: Publisher Site | Google Scholar
J C Weaver, “Electroporation theory. Concepts and mechanisms,” Methods in Molecular Biology, vol. 47, pp. 1–26, 1995.
View at: Google Scholar
S B Dev and G A Hofmann, “Electrochemotherapy–a novel method of cancer treatment,” Cancer Treatment Reviews, vol. 20, no. 1, pp. 105–115, 1994.
View at: Publisher Site | Google Scholar
G A Hofmann, S B Dev, S Dimmer, and G S Nanda, “Electroporation therapy: a new approach for the treatment of head and neck cancer,” IEEE Transactions on Biomedical Engineering, vol. 46, no. 6, pp. 752–759, 1999.
View at: Publisher Site | Google Scholar
L M Mir, O Tounekti, and S Orlowski, “Bleomycin: revival of an old drug,” General Pharmacology, vol. 27, no. 5, pp. 745–748, 1996.
View at: Publisher Site | Google Scholar
L F Glass, M L Pepine, N A Fenske, M Jaroszeski, D S Reintgen, and R Heller, “Bleomycin-mediated electrochemotherapy of metastatic melanoma,” Archives of Dermatology, vol. 132, no. 11, pp. 1353–1357, 1996.
View at: Publisher Site | Google Scholar
A Mitoro, S Kuriyama, H Tsujinoue, M Matsumoto, T Nakatani, and H Fukui, “Electrochemotherapy with bleomycin against colorectal carcinoma in a mouse model: evaluations of the dose and administration route of the drug and the electric field intensity,” International Journal of Oncology, vol. 16, no. 1, pp. 97–104, 2000.
View at: Google Scholar
O Yamaguchi, C Irisawa, K Baba, M Ogihara, T Yokota, and Y Shiraiwa, “Potentiation of antitumor effect of bleomycin by local electric pulses in mouse bladder tumor,” Tohoku Journal of Experimental Medicine, vol. 172, no. 3, pp. 291–293, 1994.
View at: Google Scholar
L F Glass, N A Fenske, M Jaroszeski et al., “Bleomycin-mediated electrochemotherapy of basal cell carcinoma,” Journal of the American Academy of Dermatology, vol. 34, no. 1, pp. 82–86, 1996.
View at: Google Scholar
G Serša, B Štabuc, M Čemažar, D Miklavčič, and Z Rudolf, “Electrochemotherapy with cisplatin: clinical experience in malignant melanoma patients,” Clinical Cancer Research, vol. 6, no. 3, pp. 863–867, 2000.
View at: Google Scholar
A Horiuchi, T Nikaido, J Mitsushita, T Toki, I Konishi, and S Fuji, “Enhancement of antitumor effect of bleomycin by low-voltage in vivo electroporation: a study of human uterine leiomyosarcomas in nude mice,” International Journal of Cancer, vol. 88, no. 4, pp. 640–644, 2000.
View at: Publisher Site | Google Scholar
M-P Rols, J-M Bachaud, P Giraud, C Chevreau, H Roche, and J Teissie, “Electrochemotherapy of cutaneous metastases in malignant melanoma,” Melanoma Research, vol. 10, no. 5, pp. 468–474, 2000.
View at: Publisher Site | Google Scholar
R M Orr, “Technology evaluation: electroporation therapy, Genetronics Inc,” Current Opinion in Molecular Therapeutics, vol. 2, no. 2, pp. 205–210, 2000.
View at: Google Scholar
C M Byrne, J F Thompson, H Johnston et al., “Treatment of metastatic melanoma using electroporation therapy with bleomycin (electrochemotherapy),” Melanoma Research, vol. 15, no. 1, pp. 45–51, 2005.
View at: Publisher Site | Google Scholar
L F Glass, M Jaroszeski, R Gilbert, D S Reintgen, and R Heller, “Intralesional bleomycin-mediated electrochemotherapy in 20 patients with basal cell carcinoma,” Journal of the American Academy of Dermatology, vol. 37, no. 4, pp. 596–599, 1997.
View at: Google Scholar
S Rodríguez-Cuevas, S Barroso-Bravo, J Almanza-Estrada, L Cristóbal-Martínez, and E González-Rodríguez, “Electrochemotherapy in primary and metastatic skin tumors: phase II trial using intralesional bleomycin,” Archives of Medical Research, vol. 32, no. 4, pp. 273–276, 2001.
View at: Publisher Site | Google Scholar
M Burian, M Formanek, and H Regele, “Electroporation therapy in head and neck cancer,” Acta Oto-Laryngologica, vol. 123, no. 2, pp. 264–268, 2003.
View at: Google Scholar
T Shimizu, T Nikaido, H Gomyo et al., “Electrochemotherapy for digital chondrosarcoma,” Journal of Orthopaedic Science, vol. 8, no. 2, pp. 248–251, 2003.
View at: Google Scholar

Copyright

Copyright © 2006 Remco de Bree et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

PDF Download Citation Order printed copies

Views

251

Downloads

913

Citations